Rukobia (fostemsavir), also known as FTR, is an attachment inhibitor. Rukobia (fostemsavir) is used as part of an antiretroviral therapy (ART) for hard-to-treat human immunodeficiency virus (HIV) infections in adults. It's taken by mouth twice daily, with or without food. One of the more common side effects of Rukobia (fostemsavir) is nausea.
Human immunodeficiency virus type 1 (HIV-1) infection in adults who've received HIV medications in the past, and:
Past HIV medications are no longer working, or
Can't tolerate side effects of past HIV medications, or
Safety concerns about past HIV medication
Rukobia (fostemsavir) is an HIV attachment inhibitor. It attaches to a protein on the surface of HIV. This prevents the virus from infecting healthy cells and spreading.
Source: DailyMed
Side effects that you should report to your care team as soon as possible:
Side effects that usually do not require medical attention (report to your care team if they continue or are bothersome)
Might work well for people who didn’t see benefits with other medications for HIV
Can take with or without food
A possible option for people with kidney or liver problems
Oral tablets smell like vinegar
Requires regular blood work and lab tests
Interacts with a lot of medications
Rukobia (fostemsavir) oral tablets might smell like vinegar, which is normal.
Get your routine blood tests done on time while you’re taking Rukobia (fostemsavir). Lab work is important to make sure that Rukobia (fostemsavir) works against the virus, and that the medication isn't causing unwanted effects.
Rukobia (fostemsavir) can interact with many medications. Some medications might need to be stopped or the dose changed before you start HIV ARV regimen. Let your provider or pharmacist know what medications you're taking, including over-the-counter products and supplements.
Talk to your provider before stopping Rukobia (fostemsavir) or any of your HIV medications. Doing so can cause the virus to spread and become harder to treat.
Make sure you contact your pharmacy to order a refill when you're running low on tablets. If you have to go to the hospital or emergency room, bring your Rukobia (fostemsavir) tablets. Not every hospital will have this medication in their pharmacy and you don't want to miss doses.
Rukobia (fostemsavir) has been shown to raise the levels of estrogen when taken together, which can cause serious blood clots. Talk with your provider if you're on birth controls with ethinyl estradiol (estrogen). Get medical attention right away if you have signs and symptoms of a heart attack (e.g., chest pain, sweating, nausea, or dizziness) or a stroke (e.g., weakness or numbness in your arms, legs, trouble speaking, blurry vision, dizziness, loss of balance, trouble walking, or confusion).
Rukobia (fostemsavir) can cause some serious health issues. This risk may be even higher for certain groups. If this worries you, talk to your doctor or pharmacist about other options.
Taking Rukobia (fostemsavir) can cause changes to your immune system called immune reconstitution syndrome. This is a medical condition where your immune system becomes stronger after you start Rukobia (fostemsavir) treatment and it begins to fight off different infections (infections your immune system was too weak to fight off before). In rare cases, your immune system may become so strong that it starts to attack normal cells in your body (autoimmune). You can experience immune reconstitution syndrome as early as during the first few weeks of Rukobia (fostemsavir) treatment, or many months later. Tell your healthcare provider right away if you start having any new symptoms, such as anxiety, hair loss, bulging eyes, or sweating, after starting Rukobia (fostemsavir).
Risk factors: History of heart problems | Taking medications that affect heart rhythm | Elderly people
Rukobia (fostemsavir) can affect your heart rhythm, which can be serious and life-threatening. Your risk is higher if you have certain conditions, including heart rhythm problems, or are taking other medications that cause heart rhythm problems. Your risk is also higher if you're over 65 years old. If you feel your chest pounding, have trouble breathing, have chest pain, or feel faint or lightheaded while taking Rukobia (fostemsavir), get medical attention right away.
Risk factors: Hepatitis B or C | History of liver problems
People who also have hepatitis B or C infections have reported liver problems after starting Rukobia (fostemsavir). Your provider will order blood tests for you before and during treatment so they can make sure this medication is safe for your liver. Let your provider know immediately if you experience signs and symptoms of liver damage, such as feeling sleepy, nausea, loss of appetite, light-colored stool, upper right stomach pain, yellowing of the skin or eyes, or dark urine.
Some medications can interfere with how your body removes Rukobia (fostemsavir). This can affect the amount of Rukobia (fostemsavir) in your body, how well it works, and the risk of side effects. It's important to know that this medication can stay in your body for 9 months or longer after your last dose.
Taking certain medications for seizures (e.g., carbamazepine (Tegretol), phenytoin (Dilantin)), St. John’s wort, or antibiotics (e.g., rifampin (Rifadin)) along with Rukobia (fostemsavir) should also be avoided. This is because these medications can lower the amount of Rukobia (fostemsavir) in your body and cause it to not work as well.
Rukobia (fostemsavir) also interferes with how your body removes other medications. For example, taking Rukobia (fostemsavir) with some statins (e.g., rosuvastatin (Crestor), simvastatin (Zocor)) can cause your body to absorb more of these statins and raise your risk for serious muscle problems.
Dosage | Quantity | Price as low as | Price per unit |
---|---|---|---|
600mg | 60 tablets | $8976.60 | $149.61 |
The typical dose is 600 mg by mouth twice daily.
Certain medications called CYP3A inducers that lower the levels of Rukobia (fostemsavir) in your body, such as carbamazepine (Tegretol), rifampin (Rifadin), or phenytoin (Dilantin)
Human immunodeficiency virus type 1 (HIV-1) infection in adults who've received HIV medications in the past, and:
Past HIV medications are no longer working, or
Can't tolerate side effects of past HIV medications, or
Safety concerns about past HIV medication
HIV (in combination with other HIV medications) when other HIV treatments haven't worked well
By signing up, I agree to GoodRx's Terms and Privacy Policy, and to receive marketing messages from GoodRx.
ClinicalInfoHIV.gov. (n.d.). Attachment inhibitor.
ClinicalInfoHIV.gov. (n.d.). Entry inhibitor.
ClinicalInfoHIV.gov. (n.d.). Immune reconstitution inflammatory syndrome (IRIS).
HIVinfo.NIH.gov. (2021). Drug resistance.
National Kidney Foundation. (n.d.). Creatinine.
Thapa, S., et al. (2023). Immune reconstitution inflammatory syndrome. StatPearls.
U.S. Food and Drug Administration. (2020). FDA approves new HIV treatment for patients with limited treatment options.
U.S. Food and Drug Administration. (2023). Drug development and drug interactions | Table of substrates, inhibitors and inducers.
ViiV Healthcare Company. (2023). Rukobia- fostemsavir tromethamine tablet, film coated, extended release [package insert]. DailyMed.
Research prescriptions and over-the-counter medications from A to Z, compare drug prices, and start saving.